GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Weed Inc (OTCPK:BUDZ) » Definitions » Debt-to-EBITDA

Weed (BUDZ) Debt-to-EBITDA : -0.11 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Weed Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Weed's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.17 Mil. Weed's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Weed's annualized EBITDA for the quarter that ended in Dec. 2023 was $-1.59 Mil. Weed's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.11.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Weed's Debt-to-EBITDA or its related term are showing as below:

BUDZ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.58   Med: -0.04   Max: 2.51
Current: 2.51

During the past 13 years, the highest Debt-to-EBITDA Ratio of Weed was 2.51. The lowest was -0.58. And the median was -0.04.

BUDZ's Debt-to-EBITDA is ranked worse than
60.73% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs BUDZ: 2.51

Weed Debt-to-EBITDA Historical Data

The historical data trend for Weed's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weed Debt-to-EBITDA Chart

Weed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.10 -0.25 -0.58 2.51

Weed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 -1.13 -1.44 0.06 -0.11

Competitive Comparison of Weed's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Weed's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Weed's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Weed's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Weed's Debt-to-EBITDA falls into.



Weed Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Weed's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.168 + 0) / 0.067
=2.51

Weed's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.168 + 0) / -1.592
=-0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Weed  (OTCPK:BUDZ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Weed Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Weed's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Weed (BUDZ) Business Description

Traded in Other Exchanges
N/A
Address
4920 North Post Trail, Tucson, AZ, USA, 85750
Weed Inc is working on or planning for several different business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations, and harvest for research, product development, processing, and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the Medical Cannabis and Hemp global market space.
Executives
Nicole M Breen director, 10 percent owner, officer: Secretary/Treasurer 4920 N. POST TRAIL, TUCSON AZ 85750
Elliot Kwestel director 5 AUERBACH LANE, LAWRENCE NY 11559
Lawrence G Dykers director 11924 N CENTAURUS PLACE, ORO VALLEY AZ 85737
Glynn A Burkhardt director, 10 percent owner, officer: Senior Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Roger Mccaslin director 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Glenn E. Martin director, 10 percent owner, officer: President and Chairman of BOD 4920 N. POST TRAIL, TUCSON AZ 85750
Robert A Metz director, officer: Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Robert A Leitzman director, officer: CFO, CAO and V.P. 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Glynn A. Burkhardt director, 10 percent owner, officer: Senior V.P. 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Donald J Steinberg director, officer: Former Officer and Director 3223 SUMAC ROAD, FALLBROOK CA 92028

Weed (BUDZ) Headlines

From GuruFocus

WEED, Inc. Acquires WEED(R) Trademarks

By ACCESSWIRE AccessWire 04-12-2019